ReP USP - Resultado da busca

Artigo de periodico
Exploring ubiquinone biosynthesis inhibition as a strategy for improving atovaquone efficacy in Malaria (2021)
Verdaguer, Ignasi Bofill; Alba, Camila Andrea Zafra ; Sussmann, R. A. C.; Zuluaga, Norma Lucía Buriticá ; Melo, H. R.; Azevedo, M. F.; Almeida, F. G.; Kimura, Emilia Akemi Shiraishi; Katzin, Alejandro Miguel
Fonte: Antimicrobial Agents and Chemotherapy. Unidade: ICB
Assuntos: PARASITOLOGIA, MALÁRIA, ANTIMALÁRICOS, PLASMODIUM FALCIPARUM, OXIGÊNIO, ANIMAIS PARASITOS, MEDICAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VERDAGUER, Ignasi Bofill et al. Exploring ubiquinone biosynthesis inhibition as a strategy for improving atovaquone efficacy in Malaria. Antimicrobial Agents and Chemotherapy, v. 65, n. 4, p. 1-19, 2021Tradução . . Disponível em: https://doi.org/10.1128/AAC.01516-20. Acesso em: 05 dez. 2025.
APA
Verdaguer, I. B., Alba, C. A. Z., Sussmann, R. A. C., Zuluaga, N. L. B., Melo, H. R., Azevedo, M. F., et al. (2021). Exploring ubiquinone biosynthesis inhibition as a strategy for improving atovaquone efficacy in Malaria. Antimicrobial Agents and Chemotherapy, 65( 4), 1-19. doi:10.1128/AAC.01516-20
NLM
Verdaguer IB, Alba CAZ, Sussmann RAC, Zuluaga NLB, Melo HR, Azevedo MF, Almeida FG, Kimura EAS, Katzin AM. Exploring ubiquinone biosynthesis inhibition as a strategy for improving atovaquone efficacy in Malaria [Internet]. Antimicrobial Agents and Chemotherapy. 2021 ; 65( 4): 1-19.[citado 2025 dez. 05 ] Available from: https://doi.org/10.1128/AAC.01516-20
Vancouver
Verdaguer IB, Alba CAZ, Sussmann RAC, Zuluaga NLB, Melo HR, Azevedo MF, Almeida FG, Kimura EAS, Katzin AM. Exploring ubiquinone biosynthesis inhibition as a strategy for improving atovaquone efficacy in Malaria [Internet]. Antimicrobial Agents and Chemotherapy. 2021 ; 65( 4): 1-19.[citado 2025 dez. 05 ] Available from: https://doi.org/10.1128/AAC.01516-20
Artigo de periodico
Perillyl alcohol reduces parasite sequestration and cerebrovascular dysfunction during experimental cerebral malaria (2021)
Rodriguez, Adriana Alejandra Marin; Murillo, Oscar ; Sussmann, Rodrigo Antonio Ceschini ; Ortolan, Luana S. ; Battagello, Daniella Sabino ; Quirino, Thatyane de Castro ; Bittencourt, Jackson Cioni ; Epiphanio, Sabrina ; Katzin, Alejandro Miguel ; Carvalho, Leonardo José de Moura
Fonte: Antimicrobial Agents and Chemotherapy. Unidades: ICB, FCF
Assuntos: MALÁRIA, ÁLCOOL, ADJUVANTES IMUNOLÓGICOS, ANATOMIA, PARASITOLOGIA, CAMUNDONGOS, CÉLULAS ENDOTELIAIS, FARMACOCINÉTICA, MACRÓFAGOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RODRIGUEZ, Adriana Alejandra Marin et al. Perillyl alcohol reduces parasite sequestration and cerebrovascular dysfunction during experimental cerebral malaria. Antimicrobial Agents and Chemotherapy, v. 65, n. 5, p. 1-14, 2021Tradução . . Disponível em: https://doi.org/10.1128/AAC.00004-21. Acesso em: 05 dez. 2025.
APA
Rodriguez, A. A. M., Murillo, O., Sussmann, R. A. C., Ortolan, L. S., Battagello, D. S., Quirino, T. de C., et al. (2021). Perillyl alcohol reduces parasite sequestration and cerebrovascular dysfunction during experimental cerebral malaria. Antimicrobial Agents and Chemotherapy, 65( 5), 1-14. doi:10.1128/AAC.00004-21
NLM
Rodriguez AAM, Murillo O, Sussmann RAC, Ortolan LS, Battagello DS, Quirino T de C, Bittencourt JC, Epiphanio S, Katzin AM, Carvalho LJ de M. Perillyl alcohol reduces parasite sequestration and cerebrovascular dysfunction during experimental cerebral malaria [Internet]. Antimicrobial Agents and Chemotherapy. 2021 ; 65( 5): 1-14.[citado 2025 dez. 05 ] Available from: https://doi.org/10.1128/AAC.00004-21
Vancouver
Rodriguez AAM, Murillo O, Sussmann RAC, Ortolan LS, Battagello DS, Quirino T de C, Bittencourt JC, Epiphanio S, Katzin AM, Carvalho LJ de M. Perillyl alcohol reduces parasite sequestration and cerebrovascular dysfunction during experimental cerebral malaria [Internet]. Antimicrobial Agents and Chemotherapy. 2021 ; 65( 5): 1-14.[citado 2025 dez. 05 ] Available from: https://doi.org/10.1128/AAC.00004-21
Artigo de periodico
Computational chemogenomics drug repositioning strategy enables the discovery of epirubicin as a new repurposed hit for Plasmodium Falciparum and P. vivax (2020)
Ferreira, Letícia Tiburcio ; Rodrigues, Juliana; Cassiano, Gustavo Capatti ; Tavella, Tatyana Almeida ; Tomaz, Kaira Cristina Peralis; Silva, Djane Clarys Baia da ; Souza, Macejane Ferreira; Lima, Marilia Nunes do Nascimento; Mottin, Melina ; Almeida, Ludimila Dias; Paim, Juliana Calit ; Puça, Maria Carolina Silva de Barros; Melo, Gisely Cardoso; Bargieri, Daniel Youssef ; Lopes, Stefanie Costa Pinto ; Lacerda, Marcus Vinicius Guimarães ; Bilsland, Elizabeth ; Sunnerhagen, Per ; Neves, Bruno Junior ; Andrade, Carolina Horta ; Cravo, Pedro Vitor Lemo ; Costa, Fabio Trindade Maranhão
Fonte: Antimicrobial Agents and Chemotherapy. Unidade: ICB
Assuntos: PARASITOLOGIA, MALÁRIA, ANTIMALÁRICOS, PLASMODIUM FALCIPARUM, MEDICAMENTO, RESISTÊNCIA MICROBIANA ÀS DROGAS, REPLICAÇÃO DO DNA, ATIVAÇÃO ENZIMÁTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERREIRA, Letícia Tiburcio et al. Computational chemogenomics drug repositioning strategy enables the discovery of epirubicin as a new repurposed hit for Plasmodium Falciparum and P. vivax. Antimicrobial Agents and Chemotherapy, v. 64, n. 9, p. 16 , 2020Tradução . . Disponível em: https://doi.org/10.1128/AAC.02041-19. Acesso em: 05 dez. 2025.
APA
Ferreira, L. T., Rodrigues, J., Cassiano, G. C., Tavella, T. A., Tomaz, K. C. P., Silva, D. C. B. da, et al. (2020). Computational chemogenomics drug repositioning strategy enables the discovery of epirubicin as a new repurposed hit for Plasmodium Falciparum and P. vivax. Antimicrobial Agents and Chemotherapy, 64( 9), 16 . doi:10.1128/aac.02041-19
NLM
Ferreira LT, Rodrigues J, Cassiano GC, Tavella TA, Tomaz KCP, Silva DCB da, Souza MF, Lima MN do N, Mottin M, Almeida LD, Paim JC, Puça MCS de B, Melo GC, Bargieri DY, Lopes SCP, Lacerda MVG, Bilsland E, Sunnerhagen P, Neves BJ, Andrade CH, Cravo PVL, Costa FTM. Computational chemogenomics drug repositioning strategy enables the discovery of epirubicin as a new repurposed hit for Plasmodium Falciparum and P. vivax [Internet]. Antimicrobial Agents and Chemotherapy. 2020 ; 64( 9): 16 .[citado 2025 dez. 05 ] Available from: https://doi.org/10.1128/AAC.02041-19
Vancouver
Ferreira LT, Rodrigues J, Cassiano GC, Tavella TA, Tomaz KCP, Silva DCB da, Souza MF, Lima MN do N, Mottin M, Almeida LD, Paim JC, Puça MCS de B, Melo GC, Bargieri DY, Lopes SCP, Lacerda MVG, Bilsland E, Sunnerhagen P, Neves BJ, Andrade CH, Cravo PVL, Costa FTM. Computational chemogenomics drug repositioning strategy enables the discovery of epirubicin as a new repurposed hit for Plasmodium Falciparum and P. vivax [Internet]. Antimicrobial Agents and Chemotherapy. 2020 ; 64( 9): 16 .[citado 2025 dez. 05 ] Available from: https://doi.org/10.1128/AAC.02041-19
Artigo de periodico
A fluorinated phenylbenzothiazole arrests the Trypanosoma cruzi cell cycle and diminishes the infection of mammalian host cells (2020)
Hernández, Roberto Issac Cuevas ; Girard, Richard Marcel Bruno Moreira; Cerón, Sarai Martínez; Silva, Marcelo Santos da ; Elias, Maria Carolina ; Crispim, Marcell ; Ferrara, José G. Trujill ; Silber, Ariel Mariano
Fonte: Antimicrobial Agents and Chemotherapy. Unidade: ICB
Assuntos: PARASITOLOGIA, DOENÇA DE CHAGAS, TRYPANOSOMA CRUZI, INFECÇÕES POR PROTOZOÁRIOS, QUIMIOTERÁPICOS, ANTIPARASITÁRIOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HERNÁNDEZ, Roberto Issac Cuevas et al. A fluorinated phenylbenzothiazole arrests the Trypanosoma cruzi cell cycle and diminishes the infection of mammalian host cells. Antimicrobial Agents and Chemotherapy, v. 64, n. 2, 2020Tradução . . Disponível em: https://doi.org/10.1128/AAC.01742-19. Acesso em: 05 dez. 2025.
APA
Hernández, R. I. C., Girard, R. M. B. M., Cerón, S. M., Silva, M. S. da, Elias, M. C., Crispim, M., et al. (2020). A fluorinated phenylbenzothiazole arrests the Trypanosoma cruzi cell cycle and diminishes the infection of mammalian host cells. Antimicrobial Agents and Chemotherapy, 64( 2). doi:10.1128/AAC.01742-19
NLM
Hernández RIC, Girard RMBM, Cerón SM, Silva MS da, Elias MC, Crispim M, Ferrara JGT, Silber AM. A fluorinated phenylbenzothiazole arrests the Trypanosoma cruzi cell cycle and diminishes the infection of mammalian host cells [Internet]. Antimicrobial Agents and Chemotherapy. 2020 ; 64( 2):[citado 2025 dez. 05 ] Available from: https://doi.org/10.1128/AAC.01742-19
Vancouver
Hernández RIC, Girard RMBM, Cerón SM, Silva MS da, Elias MC, Crispim M, Ferrara JGT, Silber AM. A fluorinated phenylbenzothiazole arrests the Trypanosoma cruzi cell cycle and diminishes the infection of mammalian host cells [Internet]. Antimicrobial Agents and Chemotherapy. 2020 ; 64( 2):[citado 2025 dez. 05 ] Available from: https://doi.org/10.1128/AAC.01742-19
Artigo de periodico
Early dissemination of qnrE1 in Salmonella enterica serovar typhimurium from livestock in south america (2019)
Monte, Daniel Farias Marinho do ; Lincopan, Nilton ; Cerdeira, Louise ; Cray, Paula J. Fedorka ; Landgraf, Mariza
Fonte: Antimicrobial Agents and Chemotherapy. Unidade: FCF
Assuntos: SALMONELLA, MICROBIOLOGIA DE ALIMENTOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MONTE, Daniel Farias Marinho do et al. Early dissemination of qnrE1 in Salmonella enterica serovar typhimurium from livestock in south america. Antimicrobial Agents and Chemotherapy, v. 63, n. 9, p. 1-3 art. e00571-19, 2019Tradução . . Disponível em: https://doi.org/10.1128/AAC.00571-19. Acesso em: 05 dez. 2025.
APA
Monte, D. F. M. do, Lincopan, N., Cerdeira, L., Cray, P. J. F., & Landgraf, M. (2019). Early dissemination of qnrE1 in Salmonella enterica serovar typhimurium from livestock in south america. Antimicrobial Agents and Chemotherapy, 63( 9), 1-3 art. e00571-19. doi:10.1128/AAC.00571-19
NLM
Monte DFM do, Lincopan N, Cerdeira L, Cray PJF, Landgraf M. Early dissemination of qnrE1 in Salmonella enterica serovar typhimurium from livestock in south america [Internet]. Antimicrobial Agents and Chemotherapy. 2019 ; 63( 9): 1-3 art. e00571-19.[citado 2025 dez. 05 ] Available from: https://doi.org/10.1128/AAC.00571-19
Vancouver
Monte DFM do, Lincopan N, Cerdeira L, Cray PJF, Landgraf M. Early dissemination of qnrE1 in Salmonella enterica serovar typhimurium from livestock in south america [Internet]. Antimicrobial Agents and Chemotherapy. 2019 ; 63( 9): 1-3 art. e00571-19.[citado 2025 dez. 05 ] Available from: https://doi.org/10.1128/AAC.00571-19
Artigo de periodico
In vitro and in vivo studies of spironolactone as an antischistosomal drug capable of clinical repurposing (2019)
Guerra, Rafael A; Silva, Marcos P; Silva, Tais C; Salvadori, Maria Cecília Barbosa da Silveira ; Teixeira, Fernanda Sá; Oliveira, Rosimeire N de; Rocha, Jefferson, A; Pinto, Pedro L S; Moraes, Josué de
Fonte: Antimicrobial Agents and Chemotherapy. Unidade: IF
Assunto: ESQUISTOSSOMOSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GUERRA, Rafael A et al. In vitro and in vivo studies of spironolactone as an antischistosomal drug capable of clinical repurposing. Antimicrobial Agents and Chemotherapy, v. 63, n. 3, p. 1-11, 2019Tradução . . Disponível em: https://doi.org/10.1128/AAC.01722-18. Acesso em: 05 dez. 2025.
APA
Guerra, R. A., Silva, M. P., Silva, T. C., Salvadori, M. C. B. da S., Teixeira, F. S., Oliveira, R. N. de, et al. (2019). In vitro and in vivo studies of spironolactone as an antischistosomal drug capable of clinical repurposing. Antimicrobial Agents and Chemotherapy, 63( 3), 1-11. doi:10.1128/AAC.01722-18
NLM
Guerra RA, Silva MP, Silva TC, Salvadori MCB da S, Teixeira FS, Oliveira RN de, Rocha J, Pinto PLS, Moraes J de. In vitro and in vivo studies of spironolactone as an antischistosomal drug capable of clinical repurposing [Internet]. Antimicrobial Agents and Chemotherapy. 2019 ; 63( 3): 1-11.[citado 2025 dez. 05 ] Available from: https://doi.org/10.1128/AAC.01722-18
Vancouver
Guerra RA, Silva MP, Silva TC, Salvadori MCB da S, Teixeira FS, Oliveira RN de, Rocha J, Pinto PLS, Moraes J de. In vitro and in vivo studies of spironolactone as an antischistosomal drug capable of clinical repurposing [Internet]. Antimicrobial Agents and Chemotherapy. 2019 ; 63( 3): 1-11.[citado 2025 dez. 05 ] Available from: https://doi.org/10.1128/AAC.01722-18
Artigo de periodico-carta/editorial
Plasmid carrying bla CTX-M-2 and bla GES-1 in extensively drug-resistant Pseudomonas aeruginosa from cerebrospinal fluid. [Carta] (2019)
Ballaben, Anelise Stella ; Galetti, Renata; Andrade, Leonardo Neves de ; Ferreira, Joseane Cristina; Garcia, Doroti de Oliveira ; Silva, Paulo da; Doi, Yohei; Darini, Ana Lúcia da Costa
Fonte: Antimicrobial Agents and Chemotherapy. Unidade: FCFRP
Assuntos: LÍQUIDO CEFALORRAQUIDIANO, ELETROFORESE, TESTES DE SENSIBILIDADE MICROBIANA, PSEUDOMONAS, PLASMÍDEOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BALLABEN, Anelise Stella et al. Plasmid carrying bla CTX-M-2 and bla GES-1 in extensively drug-resistant Pseudomonas aeruginosa from cerebrospinal fluid. [Carta]. Antimicrobial Agents and Chemotherapy. Washington: Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1128/AAC.00186-19. Acesso em: 05 dez. 2025. , 2019
APA
Ballaben, A. S., Galetti, R., Andrade, L. N. de, Ferreira, J. C., Garcia, D. de O., Silva, P. da, et al. (2019). Plasmid carrying bla CTX-M-2 and bla GES-1 in extensively drug-resistant Pseudomonas aeruginosa from cerebrospinal fluid. [Carta]. Antimicrobial Agents and Chemotherapy. Washington: Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo. doi:10.1128/AAC.00186-19
NLM
Ballaben AS, Galetti R, Andrade LN de, Ferreira JC, Garcia D de O, Silva P da, Doi Y, Darini AL da C. Plasmid carrying bla CTX-M-2 and bla GES-1 in extensively drug-resistant Pseudomonas aeruginosa from cerebrospinal fluid. [Carta] [Internet]. Antimicrobial Agents and Chemotherapy. 2019 ; 63( 7): e00186-19.[citado 2025 dez. 05 ] Available from: https://doi.org/10.1128/AAC.00186-19
Vancouver
Ballaben AS, Galetti R, Andrade LN de, Ferreira JC, Garcia D de O, Silva P da, Doi Y, Darini AL da C. Plasmid carrying bla CTX-M-2 and bla GES-1 in extensively drug-resistant Pseudomonas aeruginosa from cerebrospinal fluid. [Carta] [Internet]. Antimicrobial Agents and Chemotherapy. 2019 ; 63( 7): e00186-19.[citado 2025 dez. 05 ] Available from: https://doi.org/10.1128/AAC.00186-19
Artigo de periodico
Ciprofloxacin-mediated mutagenesis is suppressed by subinhibitory concentrations of Amikacin in Pseudomonas aeruginosa (2017)
Valencia, Estela Ynés; Esposito, Fernanda ; Spira, Beny ; Blázquez, Jesús ; Galhardo, Rodrigo da Silva
Fonte: Antimicrobial Agents and Chemotherapy. Unidade: ICB
Assuntos: MICROBIOLOGIA, PSEUDOMONAS, MUTAGÊNESE, RESISTÊNCIA MICROBIANA ÀS DROGAS, INFECÇÕES BACTERIANAS GRAM-NEGATIVAS, DNA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VALENCIA, Estela Ynés et al. Ciprofloxacin-mediated mutagenesis is suppressed by subinhibitory concentrations of Amikacin in Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy, v. 61, n. 3, p. 1-5, 2017Tradução . . Disponível em: https://doi.org/10.1128/AAC.02107-16. Acesso em: 05 dez. 2025.
APA
Valencia, E. Y., Esposito, F., Spira, B., Blázquez, J., & Galhardo, R. da S. (2017). Ciprofloxacin-mediated mutagenesis is suppressed by subinhibitory concentrations of Amikacin in Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy, 61( 3), 1-5. doi:10.1128/AAC.02107-16
NLM
Valencia EY, Esposito F, Spira B, Blázquez J, Galhardo R da S. Ciprofloxacin-mediated mutagenesis is suppressed by subinhibitory concentrations of Amikacin in Pseudomonas aeruginosa [Internet]. Antimicrobial Agents and Chemotherapy. 2017 ; 61( 3): 1-5.[citado 2025 dez. 05 ] Available from: https://doi.org/10.1128/AAC.02107-16
Vancouver
Valencia EY, Esposito F, Spira B, Blázquez J, Galhardo R da S. Ciprofloxacin-mediated mutagenesis is suppressed by subinhibitory concentrations of Amikacin in Pseudomonas aeruginosa [Internet]. Antimicrobial Agents and Chemotherapy. 2017 ; 61( 3): 1-5.[citado 2025 dez. 05 ] Available from: https://doi.org/10.1128/AAC.02107-16
Artigo de periodico
Colistin-resistant mcr-1-positive Escherichia coli on public beaches, na infectious threat emerging in recreational waters (2017)
Fernandes, Miriam Rodriguez; Sellera, Fábio Parra; Esposito, Fernanda ; Sabino, Caetano Padial; Cerdeira, Louise Teixeira; Lincopan, Nilton
Fonte: Antimicrobial Agents and Chemotherapy. Unidade: ICB
Assuntos: MICROBIOLOGIA, ESCHERICHIA COLI, INFECÇÕES POR ENTEROBACTERIACEAE, RESISTÊNCIA MICROBIANA ÀS DROGAS, GENÉTICA BACTERIANA, ÁGUA DO MAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERNANDES, Miriam Rodriguez et al. Colistin-resistant mcr-1-positive Escherichia coli on public beaches, na infectious threat emerging in recreational waters. Antimicrobial Agents and Chemotherapy, v. 61, n. 7, p. 1-4, 2017Tradução . . Disponível em: https://doi.org/10.1128/AAC.00234-17. Acesso em: 05 dez. 2025.
APA
Fernandes, M. R., Sellera, F. P., Esposito, F., Sabino, C. P., Cerdeira, L. T., & Lincopan, N. (2017). Colistin-resistant mcr-1-positive Escherichia coli on public beaches, na infectious threat emerging in recreational waters. Antimicrobial Agents and Chemotherapy, 61( 7), 1-4. doi:10.1128/AAC.00234-17
NLM
Fernandes MR, Sellera FP, Esposito F, Sabino CP, Cerdeira LT, Lincopan N. Colistin-resistant mcr-1-positive Escherichia coli on public beaches, na infectious threat emerging in recreational waters [Internet]. Antimicrobial Agents and Chemotherapy. 2017 ; 61( 7): 1-4.[citado 2025 dez. 05 ] Available from: https://doi.org/10.1128/AAC.00234-17
Vancouver
Fernandes MR, Sellera FP, Esposito F, Sabino CP, Cerdeira LT, Lincopan N. Colistin-resistant mcr-1-positive Escherichia coli on public beaches, na infectious threat emerging in recreational waters [Internet]. Antimicrobial Agents and Chemotherapy. 2017 ; 61( 7): 1-4.[citado 2025 dez. 05 ] Available from: https://doi.org/10.1128/AAC.00234-17
Artigo de periodico-carta/editorial
Complete DNA sequence of an IncM1 plasmid bearing the novel qnrE1 plasmid-mediated quinolone resistance variant and blaCTX-M-8 from Klebsiella pneumoniae sequence type 147. [Letter] (2017)
Cunha, Marcos Paulo Vieira; Davies, Yamê Miniero; Cerdeira, Louise Teixeira; Dropa, Milena; Lincopan, Nilton ; Knöbl, Terezinha
Fonte: Antimicrobial Agents and Chemotherapy. Unidades: FSP, ICB, FMVZ
Assuntos: GENÉTICA BACTERIANA, BACTÉRIAS ANAERÓBICAS GRAM-NEGATIVAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CUNHA, Marcos Paulo Vieira et al. Complete DNA sequence of an IncM1 plasmid bearing the novel qnrE1 plasmid-mediated quinolone resistance variant and blaCTX-M-8 from Klebsiella pneumoniae sequence type 147. [Letter]. Antimicrobial Agents and Chemotherapy. Washington: Faculdade de Saúde Pública, Universidade de São Paulo. Disponível em: https://doi.org/10.1128/AAC.00592-17. Acesso em: 05 dez. 2025. , 2017
APA
Cunha, M. P. V., Davies, Y. M., Cerdeira, L. T., Dropa, M., Lincopan, N., & Knöbl, T. (2017). Complete DNA sequence of an IncM1 plasmid bearing the novel qnrE1 plasmid-mediated quinolone resistance variant and blaCTX-M-8 from Klebsiella pneumoniae sequence type 147. [Letter]. Antimicrobial Agents and Chemotherapy. Washington: Faculdade de Saúde Pública, Universidade de São Paulo. doi:10.1128/AAC.00592-17
NLM
Cunha MPV, Davies YM, Cerdeira LT, Dropa M, Lincopan N, Knöbl T. Complete DNA sequence of an IncM1 plasmid bearing the novel qnrE1 plasmid-mediated quinolone resistance variant and blaCTX-M-8 from Klebsiella pneumoniae sequence type 147. [Letter] [Internet]. Antimicrobial Agents and Chemotherapy. 2017 ; 61( 9): 1-3.[citado 2025 dez. 05 ] Available from: https://doi.org/10.1128/AAC.00592-17
Vancouver
Cunha MPV, Davies YM, Cerdeira LT, Dropa M, Lincopan N, Knöbl T. Complete DNA sequence of an IncM1 plasmid bearing the novel qnrE1 plasmid-mediated quinolone resistance variant and blaCTX-M-8 from Klebsiella pneumoniae sequence type 147. [Letter] [Internet]. Antimicrobial Agents and Chemotherapy. 2017 ; 61( 9): 1-3.[citado 2025 dez. 05 ] Available from: https://doi.org/10.1128/AAC.00592-17
Artigo de periodico
An aromatic diamidine that targets kinetoplast DNA, impairs the cell cycle in Trypanosoma cruzi, and diminishes Trypomastigote release from Infected mammalian host cells (2016)
Girard, Richard Marcel Bruno Moreira ; Crispim, Marcell ; Stolić, Ivana; Damasceno, Flávia Silva ; Silva, Marcelo Santos da ; Pral, Elizabeth Mieko Furusho; Bajić, Miroslav; Silber, Ariel Mariano
Fonte: Antimicrobial Agents and Chemotherapy. Unidade: ICB
Assuntos: PARASITOLOGIA, CICLO CELULAR, TRYPANOSOMA CRUZI, DOENÇA DE CHAGAS, TRYPANOSOMA CRUZI
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GIRARD, Richard Marcel Bruno Moreira et al. An aromatic diamidine that targets kinetoplast DNA, impairs the cell cycle in Trypanosoma cruzi, and diminishes Trypomastigote release from Infected mammalian host cells. Antimicrobial Agents and Chemotherapy, v. 60, n. 10, p. 5867-5877, 2016Tradução . . Disponível em: https://doi.org/10.1128/AAC.01595-15. Acesso em: 05 dez. 2025.
APA
Girard, R. M. B. M., Crispim, M., Stolić, I., Damasceno, F. S., Silva, M. S. da, Pral, E. M. F., et al. (2016). An aromatic diamidine that targets kinetoplast DNA, impairs the cell cycle in Trypanosoma cruzi, and diminishes Trypomastigote release from Infected mammalian host cells. Antimicrobial Agents and Chemotherapy, 60( 10), 5867-5877. doi:10.1128/AAC.01595-15
NLM
Girard RMBM, Crispim M, Stolić I, Damasceno FS, Silva MS da, Pral EMF, Bajić M, Silber AM. An aromatic diamidine that targets kinetoplast DNA, impairs the cell cycle in Trypanosoma cruzi, and diminishes Trypomastigote release from Infected mammalian host cells [Internet]. Antimicrobial Agents and Chemotherapy. 2016 ; 60( 10): 5867-5877.[citado 2025 dez. 05 ] Available from: https://doi.org/10.1128/AAC.01595-15
Vancouver
Girard RMBM, Crispim M, Stolić I, Damasceno FS, Silva MS da, Pral EMF, Bajić M, Silber AM. An aromatic diamidine that targets kinetoplast DNA, impairs the cell cycle in Trypanosoma cruzi, and diminishes Trypomastigote release from Infected mammalian host cells [Internet]. Antimicrobial Agents and Chemotherapy. 2016 ; 60( 10): 5867-5877.[citado 2025 dez. 05 ] Available from: https://doi.org/10.1128/AAC.01595-15
Artigo de periodico
First Report of the Globally Disseminated IncX4 Plasmid Carrying the mcr-1 Gene in a Colistin-Resistant Escherichia coli Sequence Type 101 Isolate from a Human Infection in Brazil (2016)
Fernandes, Miriam Rodriguez; McCulloch, John Anthony; Vianello, Marco Aurélio; Silva, Quézia Moura da; Chaparro, Paula Juliana Pérez; Esposito, Fernanda ; Sartori, Luciana; Dropa, Milena; Matté, Maria Helena ; Lira, Débora P. A; Mamizuka, Elsa Masae; Lincopan, Nilton
Fonte: Antimicrobial Agents and Chemotherapy. Unidades: FSP, FCF, ICB
Assuntos: PLASMÍDEOS, ESCHERICHIA COLI, INFECÇÕES BACTERIANAS, GENÉTICA, SAÚDE PÚBLICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERNANDES, Miriam Rodriguez et al. First Report of the Globally Disseminated IncX4 Plasmid Carrying the mcr-1 Gene in a Colistin-Resistant Escherichia coli Sequence Type 101 Isolate from a Human Infection in Brazil. Antimicrobial Agents and Chemotherapy, v. 60, n. 10, p. 6415-6417, 2016Tradução . . Disponível em: https://doi.org/10.1128/AAC.01325-16. Acesso em: 05 dez. 2025.
APA
Fernandes, M. R., McCulloch, J. A., Vianello, M. A., Silva, Q. M. da, Chaparro, P. J. P., Esposito, F., et al. (2016). First Report of the Globally Disseminated IncX4 Plasmid Carrying the mcr-1 Gene in a Colistin-Resistant Escherichia coli Sequence Type 101 Isolate from a Human Infection in Brazil. Antimicrobial Agents and Chemotherapy, 60( 10), 6415-6417. doi:10.1128/AAC.01325-16
NLM
Fernandes MR, McCulloch JA, Vianello MA, Silva QM da, Chaparro PJP, Esposito F, Sartori L, Dropa M, Matté MH, Lira DPA, Mamizuka EM, Lincopan N. First Report of the Globally Disseminated IncX4 Plasmid Carrying the mcr-1 Gene in a Colistin-Resistant Escherichia coli Sequence Type 101 Isolate from a Human Infection in Brazil [Internet]. Antimicrobial Agents and Chemotherapy. 2016 ; 60( 10): 6415-6417.[citado 2025 dez. 05 ] Available from: https://doi.org/10.1128/AAC.01325-16
Vancouver
Fernandes MR, McCulloch JA, Vianello MA, Silva QM da, Chaparro PJP, Esposito F, Sartori L, Dropa M, Matté MH, Lira DPA, Mamizuka EM, Lincopan N. First Report of the Globally Disseminated IncX4 Plasmid Carrying the mcr-1 Gene in a Colistin-Resistant Escherichia coli Sequence Type 101 Isolate from a Human Infection in Brazil [Internet]. Antimicrobial Agents and Chemotherapy. 2016 ; 60( 10): 6415-6417.[citado 2025 dez. 05 ] Available from: https://doi.org/10.1128/AAC.01325-16

Unidades USP

ReP

Filtros

Unidades USP

Departamento

Autores

Autores USP

Assuntos

Agência de fomento

Indexado em

Afiliação dos autores externos não normalizada

País das instituições de afiliação dos autores externos